Content for healthcare professionals only

View all Platforms Journal

AER Home About AER Editorial Board Information for Authors Topics Current Volume Previous Volumes Special Collections Videos Submit Article

Radcliffe Platforms

Radcliffe Group Cardiology Vascular Medical Education

Content for healthcare professionals only

AER

CFR

ECR

ICR3

JAPSC

USC

AER is the official journal of the

About AER

Editorial Board

For Authors

Topics

Current Volume

Previous Volumes

Special Collections

Videos

Submit Article

EHRA 2024: Late-Breaking Science Video Collection

Published: 22 April 2024

Views:
571
Likes:
7

Views:
571
Likes:
7
Share:

Now Playing
Part 1 | Session 6 of 7
Personalised PVI: The QDOT-by-LAWT Trial
Giulio Falasconi

Up Next
7m 10s

Part 1 | Session 7 AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease
Laurent Fiorina

2m 52s

Part 2 3 Trials that Will Change My Practice With Dr Luigi Di Biase
Luigi Di Biase

4m 54s

Part 1 | Session 1 Venous Vascular Closure Vs Manual Compression: Style-AF Roland R Tilz

4m 3s

Part 1 | Session 2 FIH Clinical Series of Conformable "Single Shot" PFA Catheter for PVI Vivek Reddy

8m 5s

Part 1 | Session 3 Risk of Stroke or Embolism and AF: ARTESiA Substudy William McIntyre

2m 53s

Part 1 | Session 4 Ablation Strategies for Repeat Procedures in Recurrent AF: ASTRO Boris Schmidt

5m 26s

Part 1 | Session 5 Non-Vitamin K Antagonist Oral Anticoagulant in AHRE Patients: NOAH Julius Nikorowitsch

Average (ratings)

No ratings

Your rating

Overview

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.

More from this programme

Part 1

Expert Interviews

7 sessions
Venous Vascular Closure Vs Manual Compression: Style-AF	Watch now
FIH Clinical Series of Conformable "Single Shot" PFA Catheter for PVI	Watch now
Risk of Stroke or Embolism and AF: ARTESiA Substudy	Watch now
Ablation Strategies for Repeat Procedures in Recurrent AF: ASTRO	Watch now
Non-Vitamin K Antagonist Oral Anticoagulant in AHRE Patients: NOAH	Watch now
Personalised PVI: The QDOT-by-LAWT Trial	Watch now
AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease	Watch now

Part 2

Highlights

1 session
3 Trials that Will Change My Practice With Dr Luigi Di Biase	Watch now

About the episode

EHRA 24 - In this video, investigator, Dr Giulio Falasconi (Humanitas Research Hospital, IT) joins us to discuss the findings from the QDOT-by-LAWT trial. This study included 162 patients with paroxysmal atrial fibrillation not responding to antiarrhythmic drugs. They were retrospectively enrolled and randomized on a 1:1 basis to the QDOT-by-LAWT study group, and the control group.

Findings showed that the QDOT-by-LAWT group received a significantly reduced procedure time, reporting a median procedure time of 40 minutes as compared to 70 minutes in the control group. The results also showed a significant reduction in radiofrequency time, consisting of 6 minutes for the QDOT-by-LAWT arm compared to 25 minutes in the control group. A significant reduction in fluoroscopy time was also observed. It is also important to note significant differences in hospital complication rate.

Interview Questions:

What is the importance of this study?
What was the study design and patient population?
What are the key findings revealed at EHRA 24?
What are your take-home messages?
What further study is needed?

Recorded on-site at EHRA in Berlin, 2024.

Faculty Biographies

Giulio Falasconi

View full profile

Comments

You must be to comment. If you are not registered, you can register here.